Attached files
file | filename |
---|---|
EX-99.2 - EX-99.2 - KINDRED HEALTHCARE, INC | d330238dex992.htm |
EX-99.1 - EX-99.1 - KINDRED HEALTHCARE, INC | d330238dex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 27, 2017
KINDRED HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
Delaware | 001-14057 | 61-1323993 | ||
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(IRS Employer Identification No.) |
680 South Fourth Street
Louisville, Kentucky
(Address of principal executive offices)
40202
(Zip Code)
Registrants telephone number, including area code: (502) 596-7300
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02. | Results of Operations and Financial Condition. |
On February 27, 2017, Kindred Healthcare, Inc. (the Company) issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2016. The press release, dated February 27, 2017, is attached as Exhibit 99.1 to this Form 8-K. On February 27, 2017, the Company also made the press release available on its website at www.kindredhealthcare.com.
The information contained herein is being furnished pursuant to Item 2.02 of Form 8-K, Results of Operations and Financial Condition. This information shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the Securities Act), or the Exchange Act, nor shall this information be deemed incorporated by reference into any filing made by the Company under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 7.01. | Regulation FD Disclosure. |
Incorporated by reference is Exhibit 99.1 attached hereto, a press release issued by the Company on February 27, 2017 announcing its financial results for the fourth quarter and fiscal year ended December 31, 2016. This information is being furnished under Item 7.01 and shall not be deemed filed for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of such section nor shall this information be deemed incorporated by reference into any filing made by the Company under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 8.01. | Other Events. |
On February 27, 2017, the Company issued an additional press release announcing that its Board of Directors approved the payment of a cash dividend to its common shareholders. A cash dividend of $0.12 per common share will be paid on March 31, 2017 to all common shareholders of record as of the close of business on March 13, 2017. The press release further announced that the Companys Board of Directors has determined, following payment of the March 31, 2017 cash dividend to the Companys common shareholders, to discontinue the Companys cash dividend on its common shares and redirect the funds to repay debt and invest in growth.
The press release also announced that the Companys Board of Directors approved the scheduled March 1, 2017 installment payment of $18.75 per share of the Companys Mandatory Redeemable Preferred Stock, Series A. The installment payment will be paid on March 1, 2017 to the preferred shareholders of record as of 5:00 p.m., New York City time, on February 15, 2017.
A copy of the press release is attached hereto as Exhibit 99.2 and incorporated herein by reference.
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits
Exhibit 99.1 | Press release (earnings) dated February 27, 2017. | |
Exhibit 99.2 | Press release (dividend) dated February 27, 2017. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereto duly authorized.
KINDRED HEALTHCARE, INC. | ||||||
Date: February 28, 2017 |
By: | /s/ Joseph L. Landenwich | ||||
Joseph L. Landenwich | ||||||
General Counsel and Corporate Secretary |
EXHIBIT INDEX
Exhibit |
Description | |
99.1 | Press release (earnings) dated February 27, 2017. | |
99.2 | Press release (dividend) dated February 27, 2017. |